Search
Memorial Sloan Kettering Cancer Center (MSK) is committed not only to providing exceptional cancer care but also to ensuring access to care for everyone who needs it. Unfortunately, some patients — often those whose insurance plan offers a very narrow provider network or those who are underinsured — have trouble shouldering the significant financial burden that can come with a cancer diagnosis. MSK has a special team in place to make sure these patients can still get the care they deserve.
El Memorial Sloan Kettering Cancer Center (MSK) se compromete no solo a brindar una atención excepcional para combatir el cáncer, sino también, a asegurar el acceso a la atención para todo aquel que lo necesite. Desafortunadamente, algunos pacientes (generalmente aquellos cuyo seguro ofrece una red de servicios muy reducida o aquellos que no están asegurados) se encuentran en problemas para afrontar la gran carga financiera que conlleva un diagnóstico de cáncer. MSK cuenta con un equipo especial que se asegura de que estos pacientes puedan recibir la atención que se merecen.
According to Memorial Sloan Kettering scientists, it has to do with what the virus does to a cell’s DNA repair machinery.
Charles L. Sawyers, MD, Investigator, Howard Hughes Medical Institute (HHMI); Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM) Council, the Academy’s governing and oversight body, for a three-year term.
Scientists from Memorial Sloan Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.
Searching for cancer information online has benefits and drawbacks. Here are some tips on how to Google like a pro.
Marie-Josée and Henry R. Kravis have already revolutionized cancer research. Now they are doing it again, by supporting the exploration of the complex ecosystem that permits cancer to thrive — or not — in the body.
MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
MSK physician-scientists presented breakthrough advances in new treatment approaches for several cancer types at the 2024 ASCO Annual Meeting.